Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2020 May 22

PMID 32435855

Citations 3

Authors

Oliver J Hedge

Christel A S Bergstrom

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the performance of artificial membranes in in vitro lipolysis-permeation assays useful for absorption studies of drugs loaded in lipid-based formulations (LBFs).

Methods: Polycarbonate as well as PVDF filters were treated with hexadecane, or lecithin in n-dodecane solution (LiDo) to form artificial membranes. They were thereafter used as absorption membranes separating two compartments mimicking the luminal and serosal side of the intestine in vitro. Membranes were subjected to dispersions of an LBF that had been digested by porcine pancreatin and spiked with the membrane integrity marker Lucifer Yellow (LY). Three fenofibrate-loaded LBFs were used to explore the in vivo relevance of the assay.

Results: Of the explored artificial membranes, only LiDo applied to PVDF was compatible with lipolysis by porcine pancreatin. Formulation ranking based on mass transfer in the LiDo model exposed was the same as drug release in single-compartment lipolysis. Ranking based on observed apparent permeability coefficients of fenofibrate with different LBFs were the same as those obtained in a cell-based model.

Conclusions: The LiDo membrane was able to withstand lipolysis for a sufficient assay period. However, the assay with porcine pancreatin as digestive agent did not predict the in vivo ranking of the assayed formulations better than existing methods. Comparison with a Caco-2 based assay method nonetheless indicates that the in vitro in vivo relationship of this cell-free model could be improved with alternative digestive agents.

Citing Articles

and correlation for lipid-based formulations: Current status and future perspectives.

Huang Y, Yu Q, Chen Z, Wu W, Zhu Q, Lu Y Acta Pharm Sin B. 2021; 11(8):2469-2487.

PMID: 34522595 PMC: 8424225. DOI: 10.1016/j.apsb.2021.03.025.

Investigation of Self-Emulsifying Drug-Delivery System Interaction with a Biomimetic Membrane under Conditions Relevant to the Small Intestine.

Hedge O, Hook F, Joyce P, Bergstrom C Langmuir. 2021; 37(33):10200-10213.

PMID: 34379976 PMC: 8388123. DOI: 10.1021/acs.langmuir.1c01689.

Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery.

Buya A, Beloqui A, Memvanga P, Preat V Pharmaceutics. 2020; 12(12).

PMID: 33317067 PMC: 7764143. DOI: 10.3390/pharmaceutics12121194.

References

Griffin B, Kuentz M, Vertzoni M, Kostewicz E, Fei Y, Faisal W . Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate. Eur J Pharm Biopharm. 2013; 86(3):427-37. DOI: 10.1016/j.ejpb.2013.10.016. View

Feeney O, Crum M, McEvoy C, Trevaskis N, Williams H, Pouton C . 50years of oral lipid-based formulations: Provenance, progress and future perspectives. Adv Drug Deliv Rev. 2016; 101:167-194. DOI: 10.1016/j.addr.2016.04.007. View

Moyes S, Morris J, Carr K . Culture conditions and treatments affect Caco-2 characteristics and particle uptake. Int J Pharm. 2009; 387(1-2):7-18. DOI: 10.1016/j.ijpharm.2009.11.027. View

Avdeef A, Strafford M, Block E, Balogh M, Chambliss W, Khan I . Drug absorption in vitro model: filter-immobilized artificial membranes. 2. Studies of the permeability properties of lactones in Piper methysticum Forst. Eur J Pharm Sci. 2001; 14(4):271-80. DOI: 10.1016/s0928-0987(01)00191-9. View

Assmus F, Ross A, Fischer H, Seelig J, Seelig A . P and H NMR Studies of the Molecular Organization of Lipids in the Parallel Artificial Membrane Permeability Assay. Mol Pharm. 2016; 14(1):284-295. DOI: 10.1021/acs.molpharmaceut.6b00889. View

Shin D, Chae B, Goo Y, Yoon H, Kim C, Sohn S . Improved Dissolution and Oral Bioavailability of Valsartan Using a Solidified Supersaturable Self-Microemulsifying Drug Delivery System Containing Gelucire 44/14. Pharmaceutics. 2019; 11(2). PMC: 6409713. DOI: 10.3390/pharmaceutics11020058. View

Juenemann D, Jantratid E, Wagner C, Reppas C, Vertzoni M, Dressman J . Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles. Eur J Pharm Biopharm. 2010; 77(2):257-64. DOI: 10.1016/j.ejpb.2010.10.012. View

Alskar L, Keemink J, Johannesson J, Porter C, Bergstrom C . Impact of Drug Physicochemical Properties on Lipolysis-Triggered Drug Supersaturation and Precipitation from Lipid-Based Formulations. Mol Pharm. 2018; 15(10):4733-4744. PMC: 6209313. DOI: 10.1021/acs.molpharmaceut.8b00699. View

Tavelin S, Grasjo J, Taipalensuu J, Ocklind G, Artursson P . Applications of epithelial cell culture in studies of drug transport. Methods Mol Biol. 2002; 188:233-72. DOI: 10.1385/1-59259-185-X:233. View

10.

Kamboj S, Sethi S, Rana V . Lipid based delivery of Efavirenz: An answer to its erratic absorption and food effect. Eur J Pharm Sci. 2018; 123:199-216. DOI: 10.1016/j.ejps.2018.07.037. View

11.

Thomas N, Richter K, Pedersen T, Holm R, Mullertz A, Rades T . In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate. AAPS J. 2014; 16(3):539-49. PMC: 4012058. DOI: 10.1208/s12248-014-9589-4. View

12.

Matsson P, Bergstrom C, Nagahara N, Tavelin S, Norinder U, Artursson P . Exploring the role of different drug transport routes in permeability screening. J Med Chem. 2005; 48(2):604-13. DOI: 10.1021/jm049711o. View

13.

Bu P, Ji Y, Narayanan S, Dalrymple D, Cheng X, Serajuddin A . Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant. Eur J Pharm Sci. 2016; 99:350-360. DOI: 10.1016/j.ejps.2016.12.018. View

14.

Stillhart C, Imanidis G, Kuentz M . Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling. Pharm Res. 2013; 30(12):3114-30. DOI: 10.1007/s11095-013-0999-2. View

15.

Keemink J, Martensson E, Bergstrom C . Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro. Mol Pharm. 2019; 16(3):921-930. PMC: 6437649. DOI: 10.1021/acs.molpharmaceut.8b00811. View

16.

Cherniakov I, Izgelov D, Barasch D, Davidson E, Domb A, Hoffman A . Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration. J Control Release. 2017; 266:1-7. DOI: 10.1016/j.jconrel.2017.09.011. View

17.

Avdeef A . The rise of PAMPA. Expert Opin Drug Metab Toxicol. 2006; 1(2):325-42. DOI: 10.1517/17425255.1.2.325. View

18.

Elkhabaz A, Moseson D, Brouwers J, Augustijns P, Taylor L . Interplay of Supersaturation and Solubilization: Lack of Correlation between Concentration-Based Supersaturation Measurements and Membrane Transport Rates in Simulated and Aspirated Human Fluids. Mol Pharm. 2019; 16(12):5042-5053. DOI: 10.1021/acs.molpharmaceut.9b00956. View

19.

Siqueira Jorgensen S, Rades T, Mu H, Graeser K, Mullertz A . Exploring the utility of the Chasing Principle: influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension. Acta Pharm Sin B. 2019; 9(1):194-201. PMC: 6361727. DOI: 10.1016/j.apsb.2018.07.004. View

20.

Savla R, Browne J, Plassat V, Wasan K, Wasan E . Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm. 2017; 43(11):1743-1758. DOI: 10.1080/03639045.2017.1342654. View